Αρχική World News Efficacy of Romiplostim In the Treatment and Prevention of Recurrence of Persistent... World News Efficacy of Romiplostim In the Treatment and Prevention of Recurrence of Persistent Chemotherapy-Induced Thrombocytopenia Από Ogkologos - 26 Μαρτίου, 2026 373 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the RECITE study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ AI for early cancer detection: where are we now? Could virtual reality become a reality in cancer supportive care? EMA recommends granting a marketing authorisation for daraxonrasib MOST POPULAR Active Monitoring Promising for Women with Low-Risk Ductal Carcinoma In Situ 8 Ιανουαρίου, 2025 EMA Recommends Granting a Marketing Authorisation for Quizartinib 2 Οκτωβρίου, 2023 Efficacy of ICI Combined with Chemotherapy in Patients with Advanced Penile... 1 Οκτωβρίου, 2025 Molecular Analysis for Precision Oncology Congress 2025, Paris, France, 15-16 September 27 Αυγούστου, 2025 Φόρτωση περισσοτέρων HOT NEWS Clinical Utility of ctDNA NGS for Detecting Actionable Alterations According ESCAT... 9-Year-Old Has His Final Cancer Treatment After 3 Years – Breaks... Darolutamide Maintenance Improves Outcomes in Patients with mCRPC Who Were Previously... Genetic Testing for Bladder Cancer: What People With Cancer and Their...